Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × Chemoradiotherapy × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 7 Oropharyngeal Neoplasms 7 Rectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Nasopharyngeal Carcinoma 2 NSCLC 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sinonasal undifferentiated carcinoma 1 Sinonasal Squamous Cell Carcinoma 1 Resectable Esophageal Cancer 1 Rectal Malignant Neoplasms 1 Radiation Injuries 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Cancer Non-resectable 1 Ototoxicity 1

Interventions

Fluorouracil 14 Oxaliplatin 12 Nivolumab 11 Leucovorin 11 Capecitabine 9 Paclitaxel 8 pembrolizumab 7 Radiation 5 Irinotecan 5 durvalumab 4 Trastuzumab 4 Taxes 4 Specimen Handling 4 Radiotherapy 4 Cisplatin 4 Carboplatin 4 Biopsy 4 dehydroftorafur 3 Endoscopy 3 Drug Therapy 3 Docetaxel 3 zimberelimab 2 zanidatamab 2 tremelimumab 2 tislelizumab 2 Ramucirumab 2 Magnetic Resonance Spectroscopy 2 Folfox protocol 2 zolbetuximab 1 tucatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡